Lexpos News

/Lexpos News

MHRA Drug Safety Update: Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor) risk of psychological side effects

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance regarding the risk of psychological side effects while taking Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor). Psychological side effects such as anxiety, low mood, sleep disturbance, poor concentration, and forgetfulness have been infrequently reported in people with cystic fibrosis treated with Kaftrio. Healthcare professionals should advise patients [...]

The post MHRA Drug Safety Update: Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor) risk of psychological side effects appeared first on Community Pharmacy England.

By |May 7th, 2025|Lexpos News|Comments Off on MHRA Drug Safety Update: Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor) risk of psychological side effects

Medicine Supply Notification: Lidocaine (Xylocaine® ) 10mg/dose spray sugar free

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lidocaine (Xylocaine®) 10mg/dose spray sugar free. MSN/2025/028 Tier 2 – medium impact Date of issue: 7th May 2025 Lidocaine (Xylocaine®) 10mg/dose spray sugar free is out of stock from mid-May until late June 2025. Lidocaine 5% / Phenylephrine 0.5% nasal spray [...]

The post Medicine Supply Notification: Lidocaine (Xylocaine® ) 10mg/dose spray sugar free appeared first on Community Pharmacy England.

By |May 7th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Lidocaine (Xylocaine® ) 10mg/dose spray sugar free

Medicine Supply Notification: Buprenorphine (Reletrans® ) 5micrograms/hour and 15micrograms/hour transdermal patches

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Buprenorphine (Reletrans®) 5micrograms/hour and 15micrograms/hour transdermal patches. MSN/2025/030 Tier 2 – medium impact Date of issue: 7th May 2025 Buprenorphine (Reletrans®) 5micrograms/hour and 15micrograms/hour transdermal patches are out of stock until early July 2025. Alternative brands of buprenorphine matrix patches (Bunov®, [...]

The post Medicine Supply Notification: Buprenorphine (Reletrans® ) 5micrograms/hour and 15micrograms/hour transdermal patches appeared first on Community Pharmacy England.

By |May 7th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Buprenorphine (Reletrans® ) 5micrograms/hour and 15micrograms/hour transdermal patches

PQS: The Aspiration payment window is now open

Pharmacy owners are now able to make a claim for an Aspiration payment for the Pharmacy Quality Scheme (PQS) 2025/26 on the NHS Business Services Authority’s Manage Your Service (MYS) portal. The Aspiration payment is optional; if pharmacy owners do not want to claim it, it will not impact on the pharmacy owner’s ability to [...]

The post PQS: The Aspiration payment window is now open appeared first on Community Pharmacy England.

By |May 1st, 2025|Lexpos News|Comments Off on PQS: The Aspiration payment window is now open

April 2025 Price Concessions Final Update

The Department of Health and Social Care (DHSC) has today (30/04/2025) confirmed the following final list of price concessions for April 2025.  Drug Pack size Price concession Ascorbic acid 100mg tablets 28 £30.49 Buprenorphine 2mg sublingual tablets sugar free 7 £2.73 Carbocisteine 375mg capsules 120 £3.01 Clarithromycin 250mg/5ml oral suspension 70 £9.93 Desmopressin 120microgram sublingual [...]

The post April 2025 Price Concessions Final Update appeared first on Community Pharmacy England.

By |April 30th, 2025|Lexpos News|Comments Off on April 2025 Price Concessions Final Update